Target
tumor cell proliferation
1 abstract
Abstract
A phase II study cohort of penpulimab plus anlotinib in patients with recurrent or metastatic non-squamous cell carcinomas of head and neck.Org: National Cancer Center/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China, Chinese Academy of Medical Sciences & Peking Union Medical College, Beijing Key Laboratory of Clinical Study on Anticancer Molecular Targeted Drugs, Peking University Cancer Hospital and Institute (Beijing Cancer Hospital), Beijing, China, Gansu Provincial Cancer Hospital,